News | November 02, 2023
Zydus acquires UK based LiqMeds Group
Zydus will pay an upfront consideration of GBP 68 million and yearly earn-outs until 2026
Zydus will pay an upfront consideration of GBP 68 million and yearly earn-outs until 2026
RHTC will address a long-standing healthcare access issue for all the local population
The sBLA is supported by a usability study which confirmed that individuals over 18 years of age could self-administer
The Responsible Export Organisation (REO) certification is a distinguished recognition awarded by the Confederation of Indian Industry (CII)
_256_384.jpg)
GenWorks Health Introduces Braster Pro for breast screening & EVA for cervical screening in rural areas & communities
Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug
Eni will guarantee Dompé researchers access to its laboratories, support from the company's specialized staff, and use of its HPC5 supercomputer
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
Clinical Trial Data Services supports small to midsize sponsor companies helping them to take the next step towards market approval for their drug or device product.
Lokavant provides clinical trial intelligence
Subscribe To Our Newsletter & Stay Updated
